Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
6
100%

Phase Distribution

0

Early Stage

6

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
6(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 6 finished

Non-Completion Rate

100.0%

6 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Terminated(6)

Detailed Status

Withdrawn6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 26 (100.0%)

Trials by Status

withdrawn6100%

Recent Activity

0 active trials
Showing 5 of 6
withdrawnphase_2

Antineoplaston Therapy in Treating Women With Advanced Breast Cancer

NCT00003455
withdrawnphase_2

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

NCT00003517
withdrawnphase_2

Antineoplaston Therapy in Treating Patients With Colon Cancer

NCT00003486
withdrawnphase_2

Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT00003505
withdrawnphase_2

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

NCT00003514
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00003455Phase 2

Antineoplaston Therapy in Treating Women With Advanced Breast Cancer

Withdrawn
NCT00003517Phase 2

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Withdrawn
NCT00003486Phase 2

Antineoplaston Therapy in Treating Patients With Colon Cancer

Withdrawn
NCT00003505Phase 2

Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Withdrawn
NCT00003514Phase 2

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Withdrawn
NCT00003502Phase 2

Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6